News and Events – Chimeric Therapeutics

Press Releases

April 2023

New CLTX CAR Technology Patent Protection in India and Israel

April 2023

Phase 1 Brain Cancer Trial Approved for Initiation

April 2023

CAR T Cell Therapies Educational Webinar

April 2023

CHM 1101 GBM Abstract Accepted for ASCO 2023 Presentation

March 2023

Positive Pre-IND meeting with US FDA for Phase I CAR-T Study

March 2023

CHM to Present at Virtual Healthcare Conference

March 2023

Completion of Viral Vector Manufacturing for Phase 1 Trial

March 2023

Fourth dose cohort initiated in CHM 1101 Phase 1 trial

January 2023

Follow Up Period Completed for 3rd Cohort in CHM1101 Trial

January 2023

1st Patient Dosed in CHM0201 + Vactosertib Trial

December 2022

Completion of Dosing in 3rd Dose Cohort in CHM 1101 (CLTX CAR T) Clinical Trial

November 2022

Licence Agreement with CWRU (Supplementary Announcement)

November 2022

Exclusive Licence Agreement with CWRU for CORE-NK Platform

November 2022

Sponsored Research Agreement to Advance CORE-NK Portfolio

Events and Presentations

October 2022

On The Bid – Stockhead video series – CAR T therapy edition featuring CHM CEO Jenn Chow

September 2022

ASX Small and Mid Cap Conference – Jennifer Chow CEO 23 Sep 2022

November 2021

CHM 1101 (CLTX CAR T) Presents Positive Initial Phase 1 Clinical Data

November 2021

CHM 1101 (CLTX CAR T) Phase 1 Initial Data Release Presentation

October 2021

CEO Jennifer Chow’s presentation at AusBiotech Conference 2021

October 2021

CHM Virtual User Meeting Guide 2021

Recent Media Coverage

May 2022

CEO Jennifer Chow talks about expanding the company’s cancer trials

February 2022

CEO Jennifer Chow Presents at the FNN Investor Event Feb 2022

February 2022

Paul Hopper speaks to Matt Birney from Bulls N’ Bears

February 2022

CEO Jennifer Chow interviewed on Stockhead Feb 2022

February 2022

CEO Jennifer Chow interviewed on RAAS Feb 2022

February 2022

CEO Jennifer Chow interviewed on Proactive Investors Feb 2022

February 2022

CEO Jennifer Chow interviewed on Financial News Network Feb 2022

December 2021

CEO Interview on Positive Initial Phase 1 Clinical Data

November 2021

Rat’s Rant – The Godzilla Edition Chimeric Therapeutics (small cap CAR T bio tech play)

September 2021

Boardroom Media

Media Resources

“How Dose CAR T Work” Infographic

Background to CLTX CAR T

Background to CDH17 CAR T